Professional Title & Qualifications:
Chief Physician, PhD, Post-doctoral fellow
Specialization:
Hospital & Department：
Shanghai General Hospital, Affiliated with Shanghai Jiao Tong University School of Medicine – Department of Ophthalmology
Dr. Haiyan Wang - Ophthalmologist
Personal Biography
Dr. Haiyan Wang is a Chief Physician, PhD, and post-doctoral fellow in Ophthalmology, currently serving as the Deputy Administrative Director of the Glaucoma Sub-specialty at Shanghai First People's Hospital. She is also a Master's supervisor at Shanghai Jiao Tong University School of Medicine. Dr. Wang was a visiting scholar at the prestigious Bascom Palmer Eye Institute in the United States.
Her main research focuses on metabolic remodeling in diabetic retinopathy and clinical studies on anti-VEGF treatment for age-related macular degeneration, diabetic macular edema, and neovascular glaucoma. She was nominated for the "Jiulong Medical Award" by Shanghai Jiao Tong University for her outstanding achievements in teaching, research, and medical care.
Book an online consultation with Dr. Haiyan Wang
Areas of Expertise
-
Expert in various cataract surgeries, including senile, diabetic, and high myopia cataracts.
-
Extensive experience in managing complex cases, such as shallow anterior chambers, and performing cataract surgery for astigmatism and high myopia correction.
-
Proficient in various surgical treatments for glaucoma, including combined cataract-glaucoma surgery and minimally invasive glaucoma surgery (MIGS).
-
Skilled in minimally invasive vitrectomy for conditions like rhegmatogenous retinal detachment and diabetic retinopathy.
Clinical Highlights
-
Over 3,100 patients treated
-
100% treatment satisfaction rate
-
100% patient satisfaction with service attitude
Research and Publications
-
Principal Investigator (PI) for 2 national-level projects, 1 post-doctoral fund project, and 1 Shanghai municipal-level project.
-
Recipient of the Shanghai universities' study abroad fund for young/middle-aged teachers.
-
Published over 10 papers in SCI-indexed journals.
-
Serves as PI for 3 Phase III clinical trials for glaucoma.
-
Acts as sub-center PI managing the Shanghai Shenkang Glaucoma Special Disease Cohort Database study.
-
Project Manager (PM) for 1 Phase III clinical trial on anti-VEGF treatment for macular edema.
-
Co-investigator in multiple multicenter clinical trials on anti-VEGF treatment for age-related macular degeneration.
Social Positions
-
Member of the Glaucoma Group, Shanghai Medical Association.
-
Member of the International Cochrane Collaboration.
*The doctor’s information is sourced from the hospital’s official website or provided directly by the doctor. Due to update cycles, there may be occasional delays in reflecting the most recent changes.